ProQR Therapeutics (PRQR) Intangibles (2013 - 2018)

ProQR Therapeutics (PRQR) has reported Intangibles for 6 consecutive years, with -$217349.3 the latest figure, recorded in Q4 2018.

• Quarterly Intangibles fell 486.16% year-over-year to -$217349.3 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$217349.3 (down 486.16% YoY) and the FY2018 annual result came in at -$217349.3, down 486.16% from the prior year.
• Intangibles retreated to -$217349.3 in Q4 2018 per PRQR's latest filing, from $56.29 in the prior quarter.
• Over the last five years, Intangibles for PRQR reached as high as $235243.2 in Q4 2014 and fell as low as -$217349.3 in Q4 2018.
• A 5-year average of $67250.9 and a median of $56285.2 in 2014 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2014 — Intangibles surged 317.95% — and 2018, when it plunged 486.16%.
• Year by year, Intangibles stood at $235243.2 in 2014, then dropped by 13.5% to $203492.6 in 2015, then tumbled by 36.17% to $129888.9 in 2016, then sank by 56.67% to $56285.2 in 2017, then tumbled by 486.16% to -$217349.3 in 2018.
• According to Business Quant data, Intangibles over the past three periods registered -$217349.3, $56.29, and $56285.2 for Q4 2018, Q3 2018, and Q2 2018 respectively.